354 related articles for article (PubMed ID: 2933181)
1. Systemic and transcardiac platelet activity in acute myocardial infarction in man: resistance to prostacyclin.
Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
Circulation; 1985 Dec; 72(6):1336-45. PubMed ID: 2933181
[TBL] [Abstract][Full Text] [Related]
2. Platelet hyperactivity in acute myocardial infarction in man--effects of prostacyclin.
Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
Herz; 1986 Apr; 11(2):116-26. PubMed ID: 2939012
[TBL] [Abstract][Full Text] [Related]
3. Platelet resistance to prostacyclin. Enhancement of the antiaggregatory effect of prostacyclin by pentoxifylline.
Manrique RV; Manrique V
Angiology; 1987 Feb; 38(2 Pt 1):101-8. PubMed ID: 3030162
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic, platelet and clinical responses to prostacyclin in unstable angina pectoris.
Théroux P; Latour JG; Diodati J; Léger-Gauthier C; Morissette D; Bosch X; de Lara J; Waters D
Am J Cardiol; 1990 May; 65(16):1084-9. PubMed ID: 2109927
[TBL] [Abstract][Full Text] [Related]
5. Enhanced platelet release reaction, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease.
Zahavi J; Zahavi M
Thromb Haemost; 1985 Feb; 53(1):105-9. PubMed ID: 3158092
[TBL] [Abstract][Full Text] [Related]
6. Effects of prostacyclin during cardiopulmonary bypass in men on plasma levels of beta-thromboglobulin, platelet factor 4, thromboxane B2, 6-keto-prostaglandin F1 alpha and heparin.
Ditter H; Heinrich D; Matthias FR; Sellmann-Richter R; Wagner WL; Hehrlein FW
Thromb Res; 1983 Nov; 32(4):393-408. PubMed ID: 6197766
[TBL] [Abstract][Full Text] [Related]
7. [Platelet activation during thrombolysis and percutaneous transluminal coronary angioplasty in the acute phase of myocardial infarction].
Abe S; Maruyama I; Arima S; Yamaguchi H; Okino H; Hamasaki S; Nomoto K; Atsuchi Y; Tahara M; Tanaka H
J Cardiol; 1990; 20(4):849-59. PubMed ID: 2151948
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of the antiaggregatory activity of prostacyclin by propranolol in human platelets.
Callahan KS; Johnson AR; Campbell WB
Circulation; 1985 Jun; 71(6):1237-46. PubMed ID: 2986877
[TBL] [Abstract][Full Text] [Related]
9. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
[TBL] [Abstract][Full Text] [Related]
10. [Metabolic significance of cyclic nucleotides in the environment for fetal growth--effects of PGI2-like substance on fetal platelet function].
Kihira M; Matsumoto T; Morikawa F; Ito M
Nihon Sanka Fujinka Gakkai Zasshi; 1983 May; 35(5):691-8. PubMed ID: 6306121
[TBL] [Abstract][Full Text] [Related]
11. Effects of prostacyclin on fetal platelet function.
Matsumoto T; Kihira M; Ito M; Sugiyama Y
Biol Res Pregnancy Perinatol; 1984; 5(1):11-5. PubMed ID: 6322874
[TBL] [Abstract][Full Text] [Related]
12. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
Krishnamurthi S; Westwick J; Kakkar VV
Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
[TBL] [Abstract][Full Text] [Related]
13. Effects of smoking on platelets and on plasma thromboxane-prostacyclin balance in man.
Mehta P; Mehta J
Prostaglandins Leukot Med; 1982 Aug; 9(2):141-50. PubMed ID: 6181530
[TBL] [Abstract][Full Text] [Related]
14. Effects of propranolol therapy on platelet release and prostaglandin generation in patients with coronary heart disease.
Mehta J; Mehta P
Circulation; 1982 Dec; 66(6):1294-9. PubMed ID: 6216027
[TBL] [Abstract][Full Text] [Related]
15. The effects of continuous infusions of prostacyclin-Na (epoprostenol-sodium) on platelet counts, ADP-induced aggregation, and cyclic AMP levels in normal volunteers.
Reele SB; Miller OV; Spillers C; Gorman RR
Prostaglandins; 1983 Aug; 26(2):287-302. PubMed ID: 6316420
[TBL] [Abstract][Full Text] [Related]
16. The effect of prolonged treatment with sulphinpyrazone on thromboxane A2 and prostacyclin in man.
Viinikka L; Toivanen J; Ylikorkala O
Br J Clin Pharmacol; 1982 Sep; 14(3):456-8. PubMed ID: 6812610
[TBL] [Abstract][Full Text] [Related]
17. Platelet activation during steady state sickle cell disease.
Westwick J; Watson-Williams EJ; Krishnamurthi S; Marks G; Ellis V; Scully MF; White JM; Kakkar VV
J Med; 1983; 14(1):17-36. PubMed ID: 6224876
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia.
Schrör K; Löbel P; Steinhagen-Thiessen E
Eicosanoids; 1989; 2(1):39-45. PubMed ID: 2483819
[TBL] [Abstract][Full Text] [Related]
19. Decreased prostacyclin sensitivity of platelets in patients with Behçet's syndrome.
Wilson AP; Efthimiou J; Betteridge DJ
Eur J Clin Invest; 1988 Aug; 18(4):410-4. PubMed ID: 2971547
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of cardiovascular disorders in streptozotocin-induced diabetes in rat. II. Correlation between lipid peroxides, thromboxane A2/prostacyclin, and platelet aggregation in different stages of diabetes.
Somova L; Kamenov V; Doncheva M; Kirilov G; Vassileva M
Acta Physiol Pharmacol Bulg; 1988; 14(3):57-62. PubMed ID: 3066112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
